Paper42818643PubMed
Chemical Genetic Targeting of the LRRK2 GTPase Domain.
Prorok RE and 6 others. bioRxiv, 2026.
Cite this record
ConductScience Library. Chemical Genetic Targeting of the LRRK2 GTPase Domain. Papers, record 42818643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42818643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chemical Genetic Targeting of the LRRK2 GTPase Domain.
- Journal
- bioRxiv
- Year
- 2026
- Publication types
- Journal Article, Preprint
- Revised in PubMed
- 2026-10-09
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| F31 CA301949 | NCI NIH HHS | United States | F31CA301949 | PubMed | NIH RePORTER |
| F31 NS122434 | NINDS NIH HHS | United States | F31NS122434 | PubMed | NIH RePORTER |
References59
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32250617 | Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer. | J Med Chem | 2020 | https://conductscience.org/library/papers/32250617 | PubMed |
| 2 | 23241358 | GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2. | Hum Mol Genet | 2013 | https://conductscience.org/library/papers/23241358 | PubMed |
| 3 | 37339170 | A Nonconserved Histidine Residue on KRAS Drives Paralog Selectivity of the KRASG12D Inhibitor MRTX1133. | Cancer Res | 2023 | https://conductscience.org/library/papers/37339170 | PubMed |
| 4 | 26407721 | MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition. | J Pharmacol Exp Ther | 2015 | https://conductscience.org/library/papers/26407721 | PubMed |
| 5 | 28918051 | LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson's Disease Mouse Model. | Mol Ther Nucleic Acids | 2017 | https://conductscience.org/library/papers/28918051 | PubMed |
| 6 | 31658955 | The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients. | Cancer Discov | 2020 | https://conductscience.org/library/papers/31658955 | PubMed |
| 7 | 34088839 | Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34088839 | PubMed |
| 8 | 33997272 | SMALL MOLECULE IMAGING AGENT FOR MUTANT KRAS G12C. | Adv Ther (Weinh) | 2021 | https://conductscience.org/library/papers/33997272 | PubMed |
| 9 | 30609797 | Roco Proteins: GTPases with a Baroque Structure and Mechanism. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30609797 | PubMed |
| 10 | 25317655 | Revisiting the Roco G-protein cycle. | Biochem J | 2015 | https://conductscience.org/library/papers/25317655 | PubMed |
| 11 | 38039358 | Inhibition of Parkinson's disease-related LRRK2 by type I and type II kinase inhibitors: Activity and structures. | Sci Adv | 2023 | https://conductscience.org/library/papers/38039358 | PubMed |
| 12 | 40764514 | 14-3-3 binding maintains the Parkinson's associated kinase LRRK2 in an inactive state. | Nat Commun | 2025 | https://conductscience.org/library/papers/40764514 | PubMed |
| 13 | 34515301 | Impact of Type II LRRK2 inhibitors on signaling and mitophagy. | Biochem J | 2021 | https://conductscience.org/library/papers/34515301 | PubMed |
| 14 | 35950872 | Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding. | Biochem J | 2022 | https://conductscience.org/library/papers/35950872 | PubMed |
| 15 | 35675433 | Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/35675433 | PubMed |
| 16 | 2406906 | Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. | Science | 1990 | https://conductscience.org/library/papers/2406906 | PubMed |
| 17 | 14654223 | Roc, a Ras/GTPase domain in complex proteins. | Biochim Biophys Acta | 2003 | https://conductscience.org/library/papers/14654223 | PubMed |
| 18 | 34471232 | The KRAS-G12C inhibitor: activity and resistance. | Cancer Gene Ther | 2022 | https://conductscience.org/library/papers/34471232 | PubMed |
| 19 | 39642212 | Discovery of BBO-8520, a First-In-Class Direct and Covalent Dual Inhibitor of GTP-Bound (ON) and GDP-Bound (OFF) KRASG12C. | Cancer Discov | 2025 | https://conductscience.org/library/papers/39642212 | PubMed |
| 20 | 39255801 | Targeting Ras-, Rho-, and Rab-family GTPases via a conserved cryptic pocket. | Cell | 2024 | https://conductscience.org/library/papers/39255801 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| LRRK2 | 120892 | PubTator's text mining | https://conductscience.org/library/genes/120892 | NCBI Gene |
| RAB10 | 10890 | PubTator's text mining | https://conductscience.org/library/genes/10890 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42818643
GET https://conductscience.org/api/papers/v1/42818643/references?page=2